Gls1 inhibitors for treating disease
US-2024360121-A1 · Oct 31, 2024 · US
This page is not indexed by search engines while we improve data quality.
Mcafoos Timothy patents
Mcafoos Timothy is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mcafoos Timothy |
| Total patents | 26 |
| First publication | Aug 27, 2015 |
| Latest publication | Oct 31, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
GLS1 inhibitors for treating disease
US-11958849-B2 · Apr 16, 2024 · US
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
US-2023416261-A1 · Dec 28, 2023 · US
Gls1 inhibitors for treating disease
US-2023124815-A1 · Apr 20, 2023 · US
GLS1 inhibitors for treating disease
US-11370786-B2 · Jun 28, 2022 · US
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US-11173145-B2 · Nov 16, 2021 · US
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US-11046649-B2 · Jun 29, 2021 · US
Salts of heterocyclic modulators of hif activity for treatment of disease
US-2021137910-A1 · May 13, 2021 · US
Salts of heterocyclic modulators of HIF activity for treatment of disease
US-10888554-B2 · Jan 12, 2021 · US
Gls1 inhibitors for treating disease
US-2020407353-A1 · Dec 31, 2020 · US
Recent patents
Latest publications not already listed above.
GLS1 inhibitors for treating disease
US-10766892-B2 · Sep 8, 2020 · US
Salts of heterocyclic modulators of hif activity for treatment of disease
US-2020171017-A1 · Jun 4, 2020 · US
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US-2020024236-A1 · Jan 23, 2020 · US
Substituted heterocyclic inhibitors of ptpn11
US-2019389867-A1 · Dec 26, 2019 · US
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US-2019365718-A1 · Dec 5, 2019 · US
Gls1 inhibitors for treating disease
US-2019270736-A1 · Sep 5, 2019 · US
Salts of heterocyclic modulators of HIF activity for treatment of disease
US-10363248-B2 · Jul 30, 2019 · US
GLS1 inhibitors for treating disease
US-10344025-B2 · Jul 9, 2019 · US
GLS1 inhibitors for treating disease
US-9809588-B2 · Nov 7, 2017 · US
Gls1 inhibitors for treating disease
US-2017291895-A1 · Oct 12, 2017 · US
Salts of heterocyclic modulators of hif activity for treatment of disease
US-2017216271-A1 · Aug 3, 2017 · US
Salts of heterocyclic modulators of HIF activity for treatment of disease
US-9663504-B2 · May 30, 2017 · US
Gls1 inhibitors for treating disease
US-2016009704-A1 · Jan 14, 2016 · US
Gls1 inhibitors for treating disease
US-2016002248-A1 · Jan 7, 2016 · US
Gls1 inhibitors for treating disease
US-2016002204-A1 · Jan 7, 2016 · US
Salts of heterocyclic modulators of hif activity for treatment of disease
US-2015239876-A1 · Aug 27, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Texas | 26 |
| Board Of Regents Univ Of Texas System | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 24 |
| A61K31/4439 | 21 |
| A61K31/454 | 18 |
| A61K45/06 | 17 |
| C07D401/14 | 14 |